Why You Can't Trust Fitness Content
Headlines oversimplify. Influencers cherry-pick. We show you the full picture, backed by actual research.
Misquoted Studies
Headlines claim one thing. The actual paper says something completely different. We read the full text so you don't have to.
Overhyped Results
A 2% improvement on 12 people gets sold as a “breakthrough.” We show you effect sizes, sample sizes, and what the numbers actually mean.
Hidden Conflicts
Supplement companies funding studies. Researchers with patents. We flag conflicts of interest so you know who's behind the science.
House of Hypertrophy
Increasing resistance training volume boosts muscle growth with diminishing returns, supported by multiple clinical trials.
Higher training volume consistently leads to more muscle growth, but each additional set yields less benefit, with strong evidence from controlled studies.
Doctor Alex
Some sweeteners may increase clotting and diabetes risk, but effects vary by compound and individual, with causation unproven.
Evidence suggests certain sweeteners may be linked to cardiovascular and metabolic risks, but findings are inconsistent and not definitively causal.
![3 Epic New Studies to Build More Muscle [2026]](/_next/image?url=https%3A%2F%2Fi.ytimg.com%2Fvi%2FjfUXXKTMqNw%2Fmaxresdefault.jpg&w=3840&q=75)
Menno Henselmans
Training close to failure may not boost muscle growth as claimed, and swearing's performance benefits are inconsistent.
Some claims about muscle growth and training methods are supported by evidence, while others are contradicted or lack consistent backing.
To determine whether 1000 or 2000 IU/day of vitamin D3 is more effective than 600 IU/day in improving vascular and metabolic health in vitamin D-deficient...
To evaluate the effect of evolocumab on major adverse cardiovascular events in patients with atherosclerosis or diabetes who have not had a prior myocardial...
The study aimed to explore the effects of once-weekly exenatide on secondary cardiovascular outcomes in adults with type 2 diabetes, with and without baseline...
To determine whether liraglutide improves insulin sensitivity and glucose control in obesity and prediabetes independently of weight loss, and whether these...
Taking a drug called evolocumab can lower the chance of having a first major heart problem by 25% in people at high risk who’ve never had a heart attack or stroke before.
This drug stops a protein from destroying liver receptors that clean bad cholesterol out of the blood. More receptors mean more cholesterol is removed, which keeps it from building up in arteries. That prevents new blockages from forming and lowers the chance of a first heart attack or stroke.
Taking statins might slightly raise your chances of getting type 2 diabetes, but they do a much better job of preventing heart attacks and strokes — especially if you're already at high risk.
Liraglutide increases insulin sensitivity and lowers blood glucose levels after fasting and after meals in people with obesity and prediabetes by activating GLP-1 receptors, without requiring weight loss and differently from how DPP-4 inhibitors or dieting affect glucose.
Liraglutide works by keeping a key hormone receptor turned on longer than natural hormones can, which cuts liver sugar output and helps the body use insulin better — even without losing weight. Other methods like diet or DPP-4 inhibitors don't do the same thing.
What You Get From Every Analysis
Everything you need to understand and use research from videos and studies with confidence
Plain English Summary
What the study found, without jargon
GRADE Evidence Level
Medical-grade quality classification
Retraction Check
Verified against retraction databases
Practical Takeaways
What this means for you
Don't Get Misled. Check What's Actually True.
Start fact-checking videos and studies in seconds. No science degree needed.
Stay Updated with the Latest Science
Get evidence-based fitness and nutrition insights delivered to your inbox. No spam, just science.
Join others getting the latest research summaries and evidence-based analysis.